Published in Ann Intern Med on March 15, 1995
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int (2006) 5.50
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int (2005) 2.15
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab (2005) 1.86
Bone, sweet bone--osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol (2012) 1.73
Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest (2000) 1.67
High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab (2010) 1.64
Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol (2012) 1.46
Bone mineral density in non-insulin-dependent diabetes mellitus. Ann Intern Med (1995) 1.39
Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol (2002) 1.30
Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int (2005) 1.27
Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int (2005) 1.22
Novel insights into the relationship between diabetes and osteoporosis. Diabetes Metab Res Rev (2010) 1.19
Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int (2003) 1.19
Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes (2009) 1.17
Lower bone mass in prepubertal overweight children with prediabetes. J Bone Miner Res (2010) 1.17
Type 2 diabetes and bone fractures. Curr Opin Endocrinol Diabetes Obes (2012) 1.12
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences. Int J Endocrinol (2016) 1.09
Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 1.08
The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet (2001) 1.07
Fracture risk among First Nations people: a retrospective matched cohort study. CMAJ (2004) 0.96
Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int (2004) 0.96
Diabetes, TZDs, and Bone: A Review of the Clinical Evidence. PPAR Res (2006) 0.94
Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance? Diabetologia (2004) 0.93
Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do? Patient Prefer Adherence (2012) 0.93
Management of type 2 diabetes mellitus in older adults. Diabetes Metab J (2012) 0.92
Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int (2007) 0.89
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br J Pharmacol (2000) 0.88
Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep (2015) 0.88
A Comparative Study of the Metabolic and Skeletal Response of C57BL/6J and C57BL/6N Mice in a Diet-Induced Model of Type 2 Diabetes. J Nutr Metab (2015) 0.87
A growing troubling triad: diabetes, aging, and falls. J Aging Res (2013) 0.86
A critical review of diabetes, glycemic control, and dental implant therapy. Clin Oral Implants Res (2011) 0.85
Evaluation of bone mineral density in type 2 diabetes mellitus patients before and after treatment. Med J Armed Forces India (2012) 0.84
The interaction of ethnicity and chronic disease as risk factors for osteoporotic fractures: a comparison in Canadian Aboriginals and non-Aboriginals. Osteoporos Int (2006) 0.84
Fracture incidence and risk of osteoporosis in female type 2 diabetic patients in Korea. Diabetes Metab J (2012) 0.82
Bone mineral density and factors influencing it in Asian Indian population with type 2 diabetes mellitus. Indian J Endocrinol Metab (2014) 0.82
Evaluation of bone density measurement in type 2 diabetic postmenopausal women with hypertension and hyperlipidemia. J Menopausal Med (2015) 0.82
Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus. Osteoporos Int (2014) 0.82
Correlates of bone mineral density among postmenopausal women of African Caribbean ancestry: Tobago women's health study. Bone (2008) 0.81
Bone mineral density and its relationship with body mass index in postmenopausal women with type 2 diabetes mellitus in mainland China. J Bone Miner Metab (2009) 0.80
Diabetes mellitus, thyroid dysfunctions and osteoporosis: is there an association? J Diabetes Metab Disord (2013) 0.80
Type 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies. Aging Clin Exp Res (2016) 0.79
Childhood obesity, bone development, and cardiometabolic risk factors. Mol Cell Endocrinol (2015) 0.79
The alliance of mesenchymal stem cells, bone, and diabetes. Int J Endocrinol (2014) 0.78
Identification of candidate gene regions in the rat by co-localization of QTLs for bone density, size, structure and strength. PLoS One (2011) 0.78
Risk of fractures and bone abnormalities in postmenopausal women with type 2 diabetes mellitus. Clin Cases Miner Bone Metab (2010) 0.78
Osteoporosis in men with diabetes mellitus. J Osteoporos (2011) 0.78
The association between the serum C-peptide level and bone mineral density. PLoS One (2013) 0.77
Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors. Osteoporos Int (2014) 0.77
Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes. Osteoporos Int (2015) 0.77
The Association between Urine Albumin to Creatinine Ratio and Osteoporosis in Postmenopausal Women with Type 2 Diabetes. J Bone Metab (2016) 0.75
Validity of leptin receptor-deficiency (db/db) type 2 diabetes mellitus mice as a model of secondary osteoporosis. Sci Rep (2016) 0.75
Methodological considerations when studying the skeletal response to glucose intolerance using the diet-induced obesity model. Bonekey Rep (2016) 0.75
Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients? Br J Clin Pharmacol (2016) 0.75
Short-term caloric restriction does not reduce bone mineral density in rats with early type 2 diabetes. Endocrinol Metab (Seoul) (2014) 0.75
Advanced Glycation End Products, Diabetes, and Bone Strength. Curr Osteoporos Rep (2016) 0.75
Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag (2017) 0.75
Bone-Fat Interaction. Endocrinol Metab Clin North Am (2016) 0.75
Imaging of diabetic bone. Endocrine (2017) 0.75
Prevalence and Risk Factors of Osteoporosis Among Jordanian Postmenopausal Women Attending the National Center for Diabetes, Endocrinology and Genetics in Jordan. Biores Open Access (2017) 0.75
An update on the potential role of C-peptide in diabetes and osteoporosis. Endocrine (2017) 0.75
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67
Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91
Cardiovascular mortality in Dutch men during 1996 European football championship: longitudinal population study. BMJ (2001) 4.87
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Polymyositis: an overdiagnosed entity. Neurology (2003) 4.36
The epidemiology of heart failure. Eur Heart J (1997) 4.31
The macrophage in the persistence and pathogenesis of HIV infection. AIDS (1989) 4.06
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation (2001) 3.96
J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care (2000) 3.75
J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension (1999) 3.51
External validation is necessary in prediction research: a clinical example. J Clin Epidemiol (2003) 3.49
Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology (2012) 3.47
Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol (1999) 3.44
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37
The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet (1998) 3.26
Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study. Invest Ophthalmol Vis Sci (2000) 3.19
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18
An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int (1999) 3.07
The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07
Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation (2005) 2.99
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80
Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology (2001) 2.80
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 2.72
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia (2003) 2.66
Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet (1994) 2.65
Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med (1998) 2.64
Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis (2011) 2.61
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60
C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation (2005) 2.59
A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord (2001) 2.55
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49
A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab (1998) 2.45
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens (1995) 2.40